Retardation of Retinal Vascular Development in Apelin-Deficient Mice

OBJECTIVE—Apelin is an endogenous ligand for the G protein–coupled receptor, APJ, and participates in multiple physiological processes. To identify the roles of endogenous apelin, we investigated the phenotype of apelin-deficient (apelin-KO) mice. METHODS AND RESULTS—Apelin-KO mice showed impaired r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2008-10, Vol.28 (10), p.1717-1722
Hauptverfasser: Kasai, Atsushi, Shintani, Norihito, Kato, Hideaki, Matsuda, Satoshi, Gomi, Fumi, Haba, Ryota, Hashimoto, Hitoshi, Kakuda, Michiya, Tano, Yasuo, Baba, Akemichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1722
container_issue 10
container_start_page 1717
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 28
creator Kasai, Atsushi
Shintani, Norihito
Kato, Hideaki
Matsuda, Satoshi
Gomi, Fumi
Haba, Ryota
Hashimoto, Hitoshi
Kakuda, Michiya
Tano, Yasuo
Baba, Akemichi
description OBJECTIVE—Apelin is an endogenous ligand for the G protein–coupled receptor, APJ, and participates in multiple physiological processes. To identify the roles of endogenous apelin, we investigated the phenotype of apelin-deficient (apelin-KO) mice. METHODS AND RESULTS—Apelin-KO mice showed impaired retinal vascularization and ocular development, which were analyzed by histology, immunohistochemistry, real-time polymerase chain reaction, and the mouse corneal micropocket assay. Apelin-KO mice showed significantly impaired retinal vascularization in the early postnatal period. Retinal apelin/APJ mRNAs were transiently upregulated during the first 2 postnatal weeks but were undetectable in adults. There were no differences in VEGF or FGF2 mRNA expression, or in the morphology and localization of GFAP-positive astrocytes, in the apelin-KO retinas at P5. The corneal pocket assay showed that angiogenic responses to VEGF and FGF2 were remarkably decreased in apelin-KO mice. The reduced responses to VEGF and FGF2 in apelin-KO mice were partially restored by apelin, but apelin alone did not induce angiogenesis. CONCLUSIONS—Our results suggest that spatiotemporally regulated apelin/APJ signaling participates in retinal vascularization in a cooperative manner with VEGF or FGF2, and contributes to normal ocular development.
doi_str_mv 10.1161/ATVBAHA.108.163402
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69569115</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69569115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5708-4f1f1160ce6ca57c5764ccda913f1bf35ad4f071f47d1b821bb5f3202f8607243</originalsourceid><addsrcrecordid>eNpFkU9r3DAQxUVpaf71C-QQfGlv3s7IkiwfnWybFFIKIc1VyLJElGjtjWQn9NtXZk17Gc0bfvMYngg5R9ggCvza3j9ctjftBkFuUFQM6DtyjJyykolKvM891E3JBaNH5CSlJwBglMJHcoSSN40Eeky2d3bSsdeTH4didEWWftCheNDJzEHHYmtfbRj3OztMhR-Kdm-DH8qtdd74ZfbTG3tGPjgdkv20vqfk9_dv91c35e2v6x9X7W1peA2yZA5dPhyMFUbzOg8FM6bXDVYOO1dx3TMHNTpW99hJil3HXUWBOimgpqw6JV8Ovvs4vsw2TWrnk7Eh6MGOc1Ki4aJB5BmkB9DEMaVondpHv9Pxj0JQS3ZqzS5rqQ7Z5aWL1X3udrb_v7KGlYHPK5DD0cFFPRif_nEUhMxOC8cO3NsYJhvTc5jfbFSPVofpUS2_UAngJQWQmBWUS5HVX90ahcI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69569115</pqid></control><display><type>article</type><title>Retardation of Retinal Vascular Development in Apelin-Deficient Mice</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Kasai, Atsushi ; Shintani, Norihito ; Kato, Hideaki ; Matsuda, Satoshi ; Gomi, Fumi ; Haba, Ryota ; Hashimoto, Hitoshi ; Kakuda, Michiya ; Tano, Yasuo ; Baba, Akemichi</creator><creatorcontrib>Kasai, Atsushi ; Shintani, Norihito ; Kato, Hideaki ; Matsuda, Satoshi ; Gomi, Fumi ; Haba, Ryota ; Hashimoto, Hitoshi ; Kakuda, Michiya ; Tano, Yasuo ; Baba, Akemichi</creatorcontrib><description>OBJECTIVE—Apelin is an endogenous ligand for the G protein–coupled receptor, APJ, and participates in multiple physiological processes. To identify the roles of endogenous apelin, we investigated the phenotype of apelin-deficient (apelin-KO) mice. METHODS AND RESULTS—Apelin-KO mice showed impaired retinal vascularization and ocular development, which were analyzed by histology, immunohistochemistry, real-time polymerase chain reaction, and the mouse corneal micropocket assay. Apelin-KO mice showed significantly impaired retinal vascularization in the early postnatal period. Retinal apelin/APJ mRNAs were transiently upregulated during the first 2 postnatal weeks but were undetectable in adults. There were no differences in VEGF or FGF2 mRNA expression, or in the morphology and localization of GFAP-positive astrocytes, in the apelin-KO retinas at P5. The corneal pocket assay showed that angiogenic responses to VEGF and FGF2 were remarkably decreased in apelin-KO mice. The reduced responses to VEGF and FGF2 in apelin-KO mice were partially restored by apelin, but apelin alone did not induce angiogenesis. CONCLUSIONS—Our results suggest that spatiotemporally regulated apelin/APJ signaling participates in retinal vascularization in a cooperative manner with VEGF or FGF2, and contributes to normal ocular development.</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/ATVBAHA.108.163402</identifier><identifier>PMID: 18599802</identifier><identifier>CODEN: ATVBFA</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Adipokines ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Animals, Newborn ; Apelin ; Apelin Receptors ; Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Blood and lymphatic vessels ; Capillaries - metabolism ; Cardiology. Vascular system ; Carrier Proteins - genetics ; Carrier Proteins - metabolism ; Cornea - blood supply ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Emergency and intensive care: renal failure. Dialysis management ; Fibroblast Growth Factor 2 - metabolism ; Gene Expression Regulation, Developmental ; Genotype ; Immunohistochemistry ; Intensive care medicine ; Intercellular Signaling Peptides and Proteins ; Medical sciences ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Neovascularization, Physiologic - genetics ; Phenotype ; Receptor, TIE-2 - metabolism ; Receptors, G-Protein-Coupled - metabolism ; Retinal Vessels - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - metabolism ; Signal Transduction ; Time Factors ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2008-10, Vol.28 (10), p.1717-1722</ispartof><rights>2008 American Heart Association, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5708-4f1f1160ce6ca57c5764ccda913f1bf35ad4f071f47d1b821bb5f3202f8607243</citedby><cites>FETCH-LOGICAL-c5708-4f1f1160ce6ca57c5764ccda913f1bf35ad4f071f47d1b821bb5f3202f8607243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20686342$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18599802$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kasai, Atsushi</creatorcontrib><creatorcontrib>Shintani, Norihito</creatorcontrib><creatorcontrib>Kato, Hideaki</creatorcontrib><creatorcontrib>Matsuda, Satoshi</creatorcontrib><creatorcontrib>Gomi, Fumi</creatorcontrib><creatorcontrib>Haba, Ryota</creatorcontrib><creatorcontrib>Hashimoto, Hitoshi</creatorcontrib><creatorcontrib>Kakuda, Michiya</creatorcontrib><creatorcontrib>Tano, Yasuo</creatorcontrib><creatorcontrib>Baba, Akemichi</creatorcontrib><title>Retardation of Retinal Vascular Development in Apelin-Deficient Mice</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVE—Apelin is an endogenous ligand for the G protein–coupled receptor, APJ, and participates in multiple physiological processes. To identify the roles of endogenous apelin, we investigated the phenotype of apelin-deficient (apelin-KO) mice. METHODS AND RESULTS—Apelin-KO mice showed impaired retinal vascularization and ocular development, which were analyzed by histology, immunohistochemistry, real-time polymerase chain reaction, and the mouse corneal micropocket assay. Apelin-KO mice showed significantly impaired retinal vascularization in the early postnatal period. Retinal apelin/APJ mRNAs were transiently upregulated during the first 2 postnatal weeks but were undetectable in adults. There were no differences in VEGF or FGF2 mRNA expression, or in the morphology and localization of GFAP-positive astrocytes, in the apelin-KO retinas at P5. The corneal pocket assay showed that angiogenic responses to VEGF and FGF2 were remarkably decreased in apelin-KO mice. The reduced responses to VEGF and FGF2 in apelin-KO mice were partially restored by apelin, but apelin alone did not induce angiogenesis. CONCLUSIONS—Our results suggest that spatiotemporally regulated apelin/APJ signaling participates in retinal vascularization in a cooperative manner with VEGF or FGF2, and contributes to normal ocular development.</description><subject>Adipokines</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Apelin</subject><subject>Apelin Receptors</subject><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Capillaries - metabolism</subject><subject>Cardiology. Vascular system</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - metabolism</subject><subject>Cornea - blood supply</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Fibroblast Growth Factor 2 - metabolism</subject><subject>Gene Expression Regulation, Developmental</subject><subject>Genotype</subject><subject>Immunohistochemistry</subject><subject>Intensive care medicine</subject><subject>Intercellular Signaling Peptides and Proteins</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Neovascularization, Physiologic - genetics</subject><subject>Phenotype</subject><subject>Receptor, TIE-2 - metabolism</subject><subject>Receptors, G-Protein-Coupled - metabolism</subject><subject>Retinal Vessels - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - metabolism</subject><subject>Signal Transduction</subject><subject>Time Factors</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU9r3DAQxUVpaf71C-QQfGlv3s7IkiwfnWybFFIKIc1VyLJElGjtjWQn9NtXZk17Gc0bfvMYngg5R9ggCvza3j9ctjftBkFuUFQM6DtyjJyykolKvM891E3JBaNH5CSlJwBglMJHcoSSN40Eeky2d3bSsdeTH4didEWWftCheNDJzEHHYmtfbRj3OztMhR-Kdm-DH8qtdd74ZfbTG3tGPjgdkv20vqfk9_dv91c35e2v6x9X7W1peA2yZA5dPhyMFUbzOg8FM6bXDVYOO1dx3TMHNTpW99hJil3HXUWBOimgpqw6JV8Ovvs4vsw2TWrnk7Eh6MGOc1Ki4aJB5BmkB9DEMaVondpHv9Pxj0JQS3ZqzS5rqQ7Z5aWL1X3udrb_v7KGlYHPK5DD0cFFPRif_nEUhMxOC8cO3NsYJhvTc5jfbFSPVofpUS2_UAngJQWQmBWUS5HVX90ahcI</recordid><startdate>200810</startdate><enddate>200810</enddate><creator>Kasai, Atsushi</creator><creator>Shintani, Norihito</creator><creator>Kato, Hideaki</creator><creator>Matsuda, Satoshi</creator><creator>Gomi, Fumi</creator><creator>Haba, Ryota</creator><creator>Hashimoto, Hitoshi</creator><creator>Kakuda, Michiya</creator><creator>Tano, Yasuo</creator><creator>Baba, Akemichi</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200810</creationdate><title>Retardation of Retinal Vascular Development in Apelin-Deficient Mice</title><author>Kasai, Atsushi ; Shintani, Norihito ; Kato, Hideaki ; Matsuda, Satoshi ; Gomi, Fumi ; Haba, Ryota ; Hashimoto, Hitoshi ; Kakuda, Michiya ; Tano, Yasuo ; Baba, Akemichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5708-4f1f1160ce6ca57c5764ccda913f1bf35ad4f071f47d1b821bb5f3202f8607243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adipokines</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Apelin</topic><topic>Apelin Receptors</topic><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Capillaries - metabolism</topic><topic>Cardiology. Vascular system</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - metabolism</topic><topic>Cornea - blood supply</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Fibroblast Growth Factor 2 - metabolism</topic><topic>Gene Expression Regulation, Developmental</topic><topic>Genotype</topic><topic>Immunohistochemistry</topic><topic>Intensive care medicine</topic><topic>Intercellular Signaling Peptides and Proteins</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Neovascularization, Physiologic - genetics</topic><topic>Phenotype</topic><topic>Receptor, TIE-2 - metabolism</topic><topic>Receptors, G-Protein-Coupled - metabolism</topic><topic>Retinal Vessels - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - metabolism</topic><topic>Signal Transduction</topic><topic>Time Factors</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kasai, Atsushi</creatorcontrib><creatorcontrib>Shintani, Norihito</creatorcontrib><creatorcontrib>Kato, Hideaki</creatorcontrib><creatorcontrib>Matsuda, Satoshi</creatorcontrib><creatorcontrib>Gomi, Fumi</creatorcontrib><creatorcontrib>Haba, Ryota</creatorcontrib><creatorcontrib>Hashimoto, Hitoshi</creatorcontrib><creatorcontrib>Kakuda, Michiya</creatorcontrib><creatorcontrib>Tano, Yasuo</creatorcontrib><creatorcontrib>Baba, Akemichi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kasai, Atsushi</au><au>Shintani, Norihito</au><au>Kato, Hideaki</au><au>Matsuda, Satoshi</au><au>Gomi, Fumi</au><au>Haba, Ryota</au><au>Hashimoto, Hitoshi</au><au>Kakuda, Michiya</au><au>Tano, Yasuo</au><au>Baba, Akemichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retardation of Retinal Vascular Development in Apelin-Deficient Mice</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2008-10</date><risdate>2008</risdate><volume>28</volume><issue>10</issue><spage>1717</spage><epage>1722</epage><pages>1717-1722</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><coden>ATVBFA</coden><abstract>OBJECTIVE—Apelin is an endogenous ligand for the G protein–coupled receptor, APJ, and participates in multiple physiological processes. To identify the roles of endogenous apelin, we investigated the phenotype of apelin-deficient (apelin-KO) mice. METHODS AND RESULTS—Apelin-KO mice showed impaired retinal vascularization and ocular development, which were analyzed by histology, immunohistochemistry, real-time polymerase chain reaction, and the mouse corneal micropocket assay. Apelin-KO mice showed significantly impaired retinal vascularization in the early postnatal period. Retinal apelin/APJ mRNAs were transiently upregulated during the first 2 postnatal weeks but were undetectable in adults. There were no differences in VEGF or FGF2 mRNA expression, or in the morphology and localization of GFAP-positive astrocytes, in the apelin-KO retinas at P5. The corneal pocket assay showed that angiogenic responses to VEGF and FGF2 were remarkably decreased in apelin-KO mice. The reduced responses to VEGF and FGF2 in apelin-KO mice were partially restored by apelin, but apelin alone did not induce angiogenesis. CONCLUSIONS—Our results suggest that spatiotemporally regulated apelin/APJ signaling participates in retinal vascularization in a cooperative manner with VEGF or FGF2, and contributes to normal ocular development.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>18599802</pmid><doi>10.1161/ATVBAHA.108.163402</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 2008-10, Vol.28 (10), p.1717-1722
issn 1079-5642
1524-4636
language eng
recordid cdi_proquest_miscellaneous_69569115
source MEDLINE; Alma/SFX Local Collection; Journals@Ovid Complete
subjects Adipokines
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Animals, Newborn
Apelin
Apelin Receptors
Atherosclerosis (general aspects, experimental research)
Biological and medical sciences
Blood and lymphatic vessels
Capillaries - metabolism
Cardiology. Vascular system
Carrier Proteins - genetics
Carrier Proteins - metabolism
Cornea - blood supply
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Emergency and intensive care: renal failure. Dialysis management
Fibroblast Growth Factor 2 - metabolism
Gene Expression Regulation, Developmental
Genotype
Immunohistochemistry
Intensive care medicine
Intercellular Signaling Peptides and Proteins
Medical sciences
Mice
Mice, Inbred C57BL
Mice, Knockout
Neovascularization, Physiologic - genetics
Phenotype
Receptor, TIE-2 - metabolism
Receptors, G-Protein-Coupled - metabolism
Retinal Vessels - metabolism
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - metabolism
Signal Transduction
Time Factors
Vascular Endothelial Growth Factor A - metabolism
title Retardation of Retinal Vascular Development in Apelin-Deficient Mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T21%3A04%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retardation%20of%20Retinal%20Vascular%20Development%20in%20Apelin-Deficient%20Mice&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Kasai,%20Atsushi&rft.date=2008-10&rft.volume=28&rft.issue=10&rft.spage=1717&rft.epage=1722&rft.pages=1717-1722&rft.issn=1079-5642&rft.eissn=1524-4636&rft.coden=ATVBFA&rft_id=info:doi/10.1161/ATVBAHA.108.163402&rft_dat=%3Cproquest_cross%3E69569115%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69569115&rft_id=info:pmid/18599802&rfr_iscdi=true